Skip to main content

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Shanu Modi, MD, Discusses the DESTINY-Breast01 Trial

Dr Modi discusses the basis, clinical significance, and findings of the DESTINY-Breast01 trial of DS-8201a therapy for HER2-low breast cancer.

 

Advertisement

Advertisement

Advertisement

Advertisement